Free Infectious Disease CME 2017‑2018 | CMEList.com

 


Risky Business: Diagnosing and Treating Invasive Fungal Infections
Free Fungal Infection CME Posted by...Bernard Sklar, MD.
Free CME Credit Hours...1.0.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Slide-Video Lectures.
Target Audience...Hematologist-oncologists, medical oncologists, transplant surgeons, critical care surgeons, critical care pulmonologists, and other health care professionals involved in the treatment of patients with or at risk for invasive fungal infections.
Educational material last updated...April 18, 2017.
CME Credit Expires...April 17, 2018.
Financial Support...Astellas.
Risky Business: Diagnosing and Treating Invasive Fungal Infections consists of 3 brief lectures on the diagnosis and treatment of invasive fungal infection:
After completing Risky Business: Diagnosing and Treating Invasive Fungal Infections, you should be better able to:
• Describe the epidemiology and burden of invasive fungal infections in patients who are immunocompromised and/or Immunosuppressed.
• Incorporate the latest diagnostic techniques for invasive fungal infections to ensure that the appropriate therapy can be initiated in a timely manner.
• Integrate the latest evidence-based treatment guidelines and clinical data pertaining to the efficacy, safety, and prophylactic use of antifungal agents to optimize the management of invasive fungal infections.

Resisting Arrest: Treating Complicated Gram-negative Infections
Free Infectious Disease CME Posted by...Bernard Sklar, MD. img = images-doctorschannel/Resisting-Arrest_300x185.jpg alt text = Free Infectious Disease CME
Free CME Credit Hours...0.75.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Physicians, pharmacists, and other health professionals involved in the management of Gram-negative infections.
Educational material last updated...December 13, 2016.
CME Credit Expires...December 12, 2017.
Financial Support...Merck & Co., Inc.
Resisting Arrest: Treating Complicated Gram-negative Infections consists of 3 brief presentations about Gram-negative infections.
Upon successful completion of Resisting Arrest: Treating Complicated Gram-negative Infections, you should be better able to:
• Assess the burden and costs to the health care system when infections become resistant to antimicrobial therapy.
• Review the mechanisms of resistance as they pertain to the antimicrobial treatment of Gram-negative infections.
• Examine the spectrum of activity demonstrated by current antimicrobials in the treatment of common and complicated Gram-negative infections.
• Compare the safety and efficacy of antimicrobial agents used to treat complicated Gram-negative infections.

The Rising Role of the PCP in HCV Diagnosis and Treatment Free Infectious Disease CME
Posted by...Bernard Sklar, MD.
Free Infectious Disease CME Credit Hours...0.75.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Slide-Video Lectures.
Target Audience...Primary care physicians, family physicians/general practitioners, internal medicine physicians, infectious disease specialists, gastroenterologists, hepatologists and other health care professionals involved in the treatment and management of HCV.
Educational material last updated...May 31, 2016.
CME Credit Expires...May 31, 2017.
Financial Support...Gilead Sciences Medical Affairs.
The Rising Role of the PCP in HCV Diagnosis and Treatment consists of 3 brief lectures on the early diagnosis and treatment of hepatitis C infection:
• HCV Today: The Importance of Early Detection and Intervention
• How the HCV Treatment Revolution Impacts Primary Care Practice
• HCV Treatment in Primary Care: What the First-time Treater Needs to Know
After completing The Rising Role of the PCP in HCV Diagnosis and Treatment, you should be better able to:
• Evaluate the impact of early detection and intervention for patients with HCV on preventing disease progression, improving extrahepatic manifestations, and achieving cure.
• Apply established screening guidelines to the early and accurate detection of HCV.
Identify patients with HCV infection who may be easily treated in the primary care setting or refer to a specialist as warranted.
• Implement effective follow-up, counseling, and quality care for patients upon confirmed diagnosis of HCV.
• Differentiate new agents for HCV management based on safety, efficacy, and recommended usage.
• Apply evidence-based treatment guidelines to the effective management of patients with HCV.